Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

Explore the comprehensive diabetes support available to U.S. veterans. Here we highlight VHA benefits, the impact of obesity and mental health on diabetes risk, and...
Clinical trials are the middle step between scientific discoveries in the lab and making these discoveries available to the public. Learn how clinical trials work, the...
A new study reveals only 40% of people with diabetes undergo vital kidney screenings. Learn about the importance of eGFR and uACR tests for preventing CKD, and the...
Explore the VITAL-CGM trial, which investigates if using a combination of CGM and WeightWatchers can lower A1C in people with type 2 diabetes.
Explore the link between obesity, diabetes, and breast cancer risk. Learn how treatments like bariatric surgery and medications can reduce this risk and aid in diabetes...
Explore the benefits of Nevro's HFX spinal cord stimulation device for diabetic peripheral neuropathy. Recent studies show up to two years of pain relief and enhanced...
In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.
While some affirm the health benefits of caffeine, like improving insulin sensitivity and blood sugar, research is mixed on whether it's detrimental for people with...
Join a study investigating BMF-219, a menin inhibitor that could stimulate healthy beta cell regeneration and potentially slow diabetes progression.
Lilly’s SURMOUNT-4 trial shows that Mounjaro (tirzepatide) offers remarkable weight loss in patients with a BMI of over 30. Full SURMOUNT-3 trial results highlighted the...
Researchers find automated insulin delivery (AID) systems, the MiniMed 780G and Omnipod 5, showed significant improvement in time in range for everyday users. This real-...
Ongoing hostilities and violence across the world leave people with diabetes in crisis and without access to essential resources. What can be done to help?
Explore the profound issue of diabetes stigma and steps we can take to combat it. From the Language Matters movement to personal stories and global pledges, discover how...
This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.
Determining ideal carbohydrate intake for those with type 1 diabetes remains complex. Two studies at EASD 2023 highlight the benefits of a plant-based diet and...
Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...
People with type 1 diabetes face higher kidney risks, yet treatments approved for type 2 aren't FDA approved for them due to clinical trial gaps. The EASD 2023 panel...
A third patient with type 1 diabetes becomes insulin-independent after VX-880 stem cell treatment. Presented at the 2023 EASD conference, Vertex's early-phase trial...
Despite advancements in diabetes treatment, emergency department visits among adults with diabetes surged 21% from 2014-2018. The 2023 EASD Conference unveils updated...
Hypo-RESOLVE collaborates internationally to advance hypoglycemia understanding in diabetes. Evolving from a once-understudied concern, its Hypo-METRICS app now captures...

Pages